Portfolio strategy
ZS shares the latest trends to help you make better decisions.
Our first ZS portfolio and business development quarterly webinar of the year offered key insights for pharma leaders executing their 2024 strategies. This report, based on that same data, highlights:
- New drug success: Launches and revenue generated by new molecular entities approved in 2023
- Industry growth drivers: Which types of organizations are fueling the industry’s overall valuation increase
- Funding innovation: New funding avenues pharmaceutical companies are exploring
- Clinical trial trends: The reasons behind the decline in clinical trial volume
- Investment hotspots: Therapeutic areas attracting the most deal activity
Download the report
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
